Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Lewis · SciRah

Researcher profile · Semantic Scholar

P. Lewis

Share profile

P. Lewis — researcher profile on SciRah

h-index: 8
Works: 15
Citations: 463

Most-cited papers

Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study
K. Jordan, I. Proskorovsky, P. Lewis, J. Ishak +6 more
2013Supportive Care in Cancer132 citations Open access
Semantic Scholar
Review of health-related quality of life data in multiple myeloma patients treated with novel agents
P. Sonneveld, S. Verelst, P. Lewis, V. Gray-Schopfer +3 more
2013Leukemia104 citations Open access
Semantic Scholar
Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma
I. Proskorovsky, P. Lewis, C. Williams, K. Jordan +3 more
2014Health and Quality of Life Outcomes77 citations Open access
Semantic Scholar
Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial
M. Dimopoulos, M. Delforge, R. Hájek, M. Kropff +6 more
2013Haematologica64 citations Open access
Semantic Scholar
Factors that influence health-related quality of life in newly diagnosed patients with multiple myeloma aged ≥ 65 years treated with melphalan, prednisone and lenalidomide followed by lenalidomide maintenance: results of a randomized trial
M. Dimopoulos, A. Palumbo, R. Hájek, M. Kropff +6 more
2013Leukemia and Lymphoma39 citations Open access
Semantic Scholar
Assessment of Multiple Myeloma Patient Preferences on Treatment Choices: An International Discrete Choice Study
X. Leleu, M. Mateos, M. Delforge, P. Lewis +4 more
201511 citations
Semantic Scholar
Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment
X. Leleu, C. Kyriakou, I. Broek, P. Murphy +5 more
2017Blood Cancer Journal10 citations Open access
Semantic Scholar
Psychometric Performance Of The EORTC Quality-Of-Life Core Questionnaire (QLQ-C30) and QLQ-Multiple Myeloma (QLQ-MY20) In Relapsed/Refractory Multiple Myeloma (RRMM)
X. Leleu, M. Petrucci, M. Welslau, I. Broek +7 more
20139 citations
Semantic Scholar
Determinants of Global QOL and Physical and Social Functionality In Multiple Myeloma
K. Jordan, K. Ishak, P. Lewis, I. Proskorovsky +6 more
20105 citations
Semantic Scholar
Melphalan, Prednisone and Lenalidomide Followed by Lenalidomide Maintenance Improves Health-Related Quality of Life (HRQoL), with Newly Diagnosed Multiple Myeloma (NDMM) Patients >= 65 Years Benefiting From Delays in Disease Progression
M. Dimopoulos, M. Delforge, R. Hájek, M. Kropff +6 more
20114 citations
Semantic Scholar
Melphalan, Prednisone and Lenalidomide Followed by Lenalidomide Maintenance Displays Treatment Characteristics Favourable to Global Quality of Life in Newly Diagnosed Multiple Myeloma (NDMM) Patients ≥ 65 Years,
M. Dimopoulos, A. Palumbo, R. Hájek, M. Kropff +6 more
20114 citations
Semantic Scholar
Continued Treatment Duration, Drug dosing and Health-Related Quality Of Life (HRQoL) Of Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Receiving 2nd and 3rd Line Treatments: Results From a European Multicentre Study
X. Leleu, C. Kyriakou, I. Broek, P. Murphy +4 more
20133 citations
Semantic Scholar
Levels of Discordance Between Patients’ and Physicians’ Perceptions of Patients’ Health-Related Quality of Life (HRQoL) in Relapsed/Refractory Multiple Myeloma (RRMM) – a Cross-Cultural Perspective
X. Leleu, I. Broek, C. Kyriakou, P. Murphy +5 more
20151 citations
Semantic Scholar
PCN75 COST-EFFECTIVENESS OF THALIDOMIDE COMBINED WITH MELPHALAN AND PREDNISONE IN PREVIOUSLY UNTREATED MULTIPLE MYELOMA IN WALES
I. Joseph, T. Facon, P. Lewis, H. Deniz +1 more
20091 citations Open access
Semantic Scholar
IMPACT OF ECOG PERFORMANCE STATUS ON OVERALL SURVIVAL AND HRQOL IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS FROM THE MM-003 TRIAL OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE (DEX) vs HIGH-DOSE DEX
K. Weisel, J. S. San Miguel, K. Song, M. Delforge +5 more
20140 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Kyriakou×7
Invite
C. Kyriakou — researcher profile on SciRah
M. Delforge×6
Invite
M. Delforge — researcher profile on SciRah
M. Petrucci×6
Invite
M. Petrucci — researcher profile on SciRah
M. Dimopoulos×5
Invite
M. Dimopoulos — researcher profile on SciRah

×5

Invite

X. Leleu — researcher profile on SciRah

Invite

R. Hájek — researcher profile on SciRah

Invite

M. Kropff — researcher profile on SciRah

Jingshan Zhang×4

Invite

Jingshan Zhang — researcher profile on SciRah

Invite

J. Mei — researcher profile on SciRah

Invite

I. Broek — researcher profile on SciRah

Invite

P. Murphy — researcher profile on SciRah

Invite

P. Bacon — researcher profile on SciRah